The 'facts' that most women and clinicians consider in making the decision whether to use hormone replacement therapy are frequently wrong or incorrectly applied says Professor Robert D Langer in a paper titled "The evidence ...
Mar 13, 2017
0
3
Hormone replacement therapy has long been controversial as studies have associated it with health benefits and risks. While some studies suggest that it lowers the risk of osteoporosis and improves some aspects of heart health, ...
Mar 8, 2017
0
2
Men who used testosterone replacement therapy to treat symptoms of androgen deficiency had a 33 percent lower risk of cardiovascular events such as heart attacks and stroke compared to those who did not receive any hormone ...
Feb 21, 2017
0
10
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Feb 16, 2017
0
2
A higher volume of a certain type of fat that surrounds the heart is significantly associated with a higher risk of heart disease in women after menopause and women with lower levels of estrogen at midlife, according to new ...
Jan 30, 2017
0
70
When flawed clinical research is reported in the media with hype and sensationalism, it has the potential to have a devastating effect on patients, physicians, the scientific community and eventually society as a whole.
Dec 8, 2016
0
0
Dear Mayo Clinic: I just turned 30 and recently was diagnosed with Hashimoto's thyroiditis. I'm wondering about whether it can be cured or if I will have to take medication for the rest of my life. I've read the Autoimmune ...
Nov 28, 2016
0
6
So you missed a period. Or two. You think to yourself, "I'm too young for menopause. Right?"
Nov 15, 2016
0
1
Risk of death from a sudden loss of heart function was significantly greater in patients with thyroid hormone levels at the higher end of normal range, compared to patients with levels at the lower end, according to new research ...
Sep 6, 2016
0
0
Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA, European Union (EU) and, though to a smaller degree, in Japan by 2020, according to new research published ...
Sep 5, 2016
0
96
